Navigation Links
Advanced Life Sciences to Host 2008 First Quarter Financial Results Conference Call and Webcast
Date:5/1/2008

CHICAGO, May 1 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases today announced that it will host a conference call and webcast discussing the Company's 2008 first quarter results on Wednesday, May 7, 2008 at 10:00 a.m. (EDT). Michael T. Flavin, Ph.D., Chairman & Chief Executive Officer, as well as other members of the management team, will also present an update on the Company. A press release reporting the 2008 first quarter results will be issued before the U.S. stock markets open on Wednesday, May 7, 2008.

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced Life Sciences corporate website http://www.advancedlifesciences.com . Alternatively, callers may participate in the conference call by dialing 888-679-8033 (domestic) or 617-213-4846 (international). The passcode for the conference call is 94054446. A replay of the conference call will be available until May 14, 2008. Callers may access the telephone replay by dialing 888-286-8010 (domestic) or 617-801-6888 (international), passcode 36406348. Investors are advised to dial into the call at least ten minutes prior to the call to register. Participants may pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=P9JDGPHR6 . Pre-registrants will be issued a pin number to use when dialing into the live call
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)... CeloNova BioSciences, Inc., annou...h it is commercializing the,CATANIA(TM) Coronary ...t,system that has not had any stent thrombosis in...for purchase throughout Europe and now some Middle...ansion ongoing. Concurrently,CeloNova notes that...
(Date:12/3/2008)... A key element of Carpenter,s EnviroStep&tra...Active Layer RS moisture barrier film is laminated...ls or liquids from soaking in. , ... DuPont today announced it has introduced DuPont&... barrier films for use in carpet cushioning. , , ,...
(Date:12/3/2008)...nis will Outline How Technology Can Solve Pressing... , KINGSTON, ON, Dec. 3 /PRNewswire/ - Dr. D...(PPI), is one of four leading experts speaking at ...Conference underway in Poznan , Poland. Dr. Dennis...s in the 20th Century and the role it will play in...
(Date:12/3/2008)... , CALGARY, Dec. 3 /PRNewswire-FirstCall/ - S...company developing protein pharmaceuticals in crop...hase I/II clinical trial of its plant-produced ins...s. The trial, taking place in the United Kingdom (... three-arm study (SBS-1000 insulin and two commerc...
Breaking Biology Technology:CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion 2DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion 3DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion 4Leading Canadian Scientist to speak at UN Climate Change Conference 2SemBioSys begins phase I/II trial of insulin produced in plant seeds 2SemBioSys begins phase I/II trial of insulin produced in plant seeds 3
..., , , , , , , There is...at can be applied to all PCR amplifications. For e...nce of primer used, the annealing temperatures ,...ing the optimal or the , most stringent ann...results , and efficient amplification of a ...
..., , , , , , , Problems... fragment using the PCR* are an everyday occurrenc...ondary bands may form after the PCR reaction, whic...es (cycle sequencing, mutation detection, , ...ult. In such cases, PCR , conditions must b...
...Optimizing the Direct Amplification of Missing cDN...ler gradient , , , , , , ,...ral Botany, University of Hamburg Christian Rohrer... , , , , , , Introduction...ion forms the basis for detailed , analys...
..., , , , , , , , ...ty of Illinois in Chicago, , USA , ...estbury, NY, USA , , Introduct...a fragment of foreign DNA that has been incorporat...ethod of introducing recombinant DNA , in...
Other Biology Technology:PCR Optimization 2PCR Optimization 3Using Gradient PCR to determine the optimum annealing temperature. 2Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 2Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 3Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 4Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 5The use of TaqMaster PCR Enhancer 2The use of TaqMaster PCR Enhancer 3The use of TaqMaster PCR Enhancer 4The use of TaqMaster PCR Enhancer 5
(Date:12/3/2008)... WASHINGTON Synthetic biology promises to enable ...illion people who suffer from malaria, and to crea...ld,s energy problems. But the science and its app...ologists playing God? Are these scientists purpos...synthetic biology researchers unintentionally equi...
(Date:12/2/2008)... At the Savannah River Site in South Carolina, the...of the surrounding forest. No, they,re not crop c...ng longleaf pine forest ecosystems. Biologists at...aborators at North Carolina State University, the ...ngton have created these ecological patches with t...
(Date:12/2/2008)... This release is available in French . , P...iversity of California, Berkeley, have announced a...led epigenetics. They have demonstrated for the fi... silencing in plants. , The findings are import...lation in the continuing quest to breed enhanced c...
(Date:12/2/2008)... Converting forests or fields to biofuel crops can...pending on where and which biofuel crops are use...month. , The researchers analyzed data from doze...l crops can influence the carbon content of the so...l Global Change Biology Bioenergy . , Plants us...
Breaking Biology News(10 mins):Synthetic biology: Is ethics a showstopper? 2Study on wildlife corridors shows how they work over time 2Study on wildlife corridors shows how they work over time 3Study on wildlife corridors shows how they work over time 4Plants display 'molecular amnesia' 2Plants display 'molecular amnesia' 3Replacing corn with perennial grasses improves carbon footprint of biofuels 2Replacing corn with perennial grasses improves carbon footprint of biofuels 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 1Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 4Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 5Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 6Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 7Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 8Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 9Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 10Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6524 11Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast 6522 1Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast 6522 2FDA Updates Label for AVANDIA 28R 29 to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years 2623 1FDA Updates Label for AVANDIA 28R 29 to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years 2623 2FDA Updates Label for AVANDIA 28R 29 to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years 2623 3LUMEDX Introduces Next Generation Cardiology PACS Solution 23879 1LUMEDX Introduces Next Generation Cardiology PACS Solution 23879 2
...first identified in a cabbage-eating moth may one ...o viruses for gene therapy, researchers say. , ,...terized jumping genes, or transposons, to insert t...change, such as making the cell resistant to damag...Bac transposon was five to 10 times better than th...
...the University of California, Los Angeles have def...that persists for years in almost a third of breas...y 1 issue of Clinical Cancer Research. , The ke...ir immune systems. , "These studies identify a b...urvivors that is implemented by inflammation," sai...
...ed study by investigators at the Center for AIDS R...ríguez, MD, along with a nationwide team of AIDS/H...ing about the role of measurements of the amount o...ting a patient,s ability to fight off the disease.... (Journal of the American Medical Association), in...
...e found for the first time that tarantulas can pro...ets, a discovery with profound implications for wh... , Adam Summers, a UC Irvine professor of ecology ...ientists who made the discovery using zebra tarant...ntulas secrete silk from spigots on their legs, al...
Other Biology News:Jumping gene could provide non-viral alternative for gene therapy 2Jumping gene could provide non-viral alternative for gene therapy 3Inflammation markers identify fatigue in breast cancer survivors 2AIDS study challenges conventional treatment guidelines for HIV patients 2AIDS study challenges conventional treatment guidelines for HIV patients 3Tarantulas produce silk from their feet 2
X-Gal ,MOLECULAR BIOLOGY GRADE ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C 14 H 15 Br Cl N O 6 ,M.W.= 408.63 ,Assay: Greater than 99% (HPLC) ,Solution: Clear (2% in DMF) ,Biological Act
Vybrant Multicolor Cell-Labeling Kit *DiO DiI DiD solutions 1 mL each* from Molecular Probes (Invitrogen)
...ulation: 10mM HEPES, pH 7.4, 150mM NaCl, 0.02% Bri...ites: For Specific Activity data, refer to the Cer.... Purification: ammonium salt precipitation follow...romatography Quality Assurance: routinely evaluate...
Antibody Purification Specificity: Antibody Purification
Biology Products: